
The publications of five prospective randomized trials have made 2015 a milestone in the development of stroke therapy. Up till then, IV rtPA had been the only evidence-based recanalizing treatment for ischemic stroke.In this article we review the results of five trials: MR CLEAN, ESCAPE, EXTEND IA, SWIFT PRIME, and REVASCAT.
Stroke, Survival Rate, Evidence-Based Medicine, Treatment Outcome, Mechanical Thrombolysis, Risk Factors, Operative Time, Prevalence, Humans, Randomized Controlled Trials as Topic
Stroke, Survival Rate, Evidence-Based Medicine, Treatment Outcome, Mechanical Thrombolysis, Risk Factors, Operative Time, Prevalence, Humans, Randomized Controlled Trials as Topic
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 2 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
